Medibeacon Logo
Skip to content
  • Products
    • Nephrology
      • The Clinical Need
      • Current Clinical Practice
      • Renal Function System
    • Pipeline
    • Preclinical
  • About
    • History
    • Leadership
    • Scientific Advisory Board
    • Clinical Leadership
    • Board of Directors
    • News
  • Publications
    • Peer Reviewed Publications
    • Proceedings Papers
    • Posters
    • Review Papers
    • Industry Literature
  • Patents
  • Contact
patent icon

Latest Results from the On-going Clinical Studies Utilizing the Novel Fluorescent Tracer Agent MB-­102 for Transdermal Glomerular Filtration Rate Measurement

Richard B. Dorshow, Martin P. Debreczeny, James R. Johnson, Jeng-­Jong Shieh, Thomas E. Rogers, Kevin J. Martin, and Daniel W. Coyne, MediBeacon Inc., Division of Nephrology, St. Louis University, Division of Nephrology, Washington University in St. Louis, presented at the 23rd International Conference on Advances in Critical Care Nephrology “AKI&CRRT 2018”, San Diego, CA, 2018.

patent icon

MB-102 Clearance During Ex Vivo Continuous Renal Replacement Therapy

Soo Min Jang, Jeng-Jong, Richard B. Dorshow, Bruce A. Mueller, Department of Clinical Pharmacy, College of Pharmacy, Univeristy of Michigan, presented at the 23rd International Conference on Advances in Critical Care Nephrology “AKI&CRRT 2018”, San Diego, CA, 2018.

patent icon

Clinical Study Results of a Real-Time Point-of-Care Glomerular Filtration Rate Measurement

Richard B. Dorshow, Martin P. Debreczeny, James R. Johnson, Jeng-Jong Shieh, Thomas E. Rogers, Kevin J. Martin, Daniel W. Coyne, presented at the American Society of Nephrology Kidney Week Meeting, New Orleans, LA, 2017.

patent icon

Initial Clinical Trial Results of a Real-Time Point-of-Care Glomerular Filtration Rate Measurement Utilizing a Novel Fluorescent Tracer Agent

Richard B. Dorshow, Martin P. Debreczeny, Jeffrey C. Fink, and Thomas C. Dowling, presented at the American Society of Nephrology Kidney Week Meeting, San Diego, CA, 2015.

patent icon

Real-time point-of-care measurement of impaired renal function in a rat acute injury model employing exogenous fluorescent tracer agents

Richard B. Dorshow, Richard M. Fitch, Karen P. Galen, Jolette K. Wojdyla, Amruta R. Poreddy, John N. Freskos, Raghavan Rajagopalan, Jeng-Jong Shieh, and Sevag G. Demirjian, presented at the BiOS Symposium, Photonics West, San Francisco, CA, 2013.

© 2019 MediBeacon All Rights Reserved.
  • Home
  • Products
  • About
  • News
  • Publications
  • Patents
  • Contact
  • Follow Medibeacon on Twitter
  • Follow Medibeacon on LinkedIn

The Transdermal GFR Monitor is not yet approved for sale.
All animations are intended to be merely conceptual and are not meant to convey exact representations of anatomy, physiology, structure, positioning, or performance of the Transdermal GFR Monitor technology.